BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 28873267)

  • 1. Administration of adjuvant chemotherapy in older patients with Stage III colon cancer: an observational study.
    van den Broek CBM; Puylaert CCEM; Breugom AJ; Bastiaannet E; de Craen AJM; van de Velde CJH; Liefers GJ; Portielje JEA
    Colorectal Dis; 2017 Oct; 19(10):O358-O364. PubMed ID: 28873267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilisation of Adjuvant Chemotherapy and 5-Year Survival Analysis of Prospectively Recorded Cohort Data for Older Adults Versus Younger Adults with Resected Primary Colon Cancer.
    Shafiei M; Beale P; Blinman P
    J Gastrointest Cancer; 2020 Sep; 51(3):988-997. PubMed ID: 31811472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of adjuvant chemotherapy on survival benefit in stage III colon cancer patients stratified by age: a Japanese real-world cohort study.
    Kawamura H; Morishima T; Sato A; Honda M; Miyashiro I
    BMC Cancer; 2020 Jan; 20(1):19. PubMed ID: 31906959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time trends in chemotherapy (administration and costs) and relative survival in stage III colon cancer patients - a large population-based study from 1990 to 2008.
    van den Broek CB; Bastiaannet E; Dekker JW; Portielje JE; de Craen AJ; Elferink MA; van de Velde CJ; Liefers GJ; Kapiteijn E
    Acta Oncol; 2013 Jun; 52(5):941-9. PubMed ID: 23145507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer.
    Zuckerman IH; Rapp T; Onukwugha E; Davidoff A; Choti MA; Gardner J; Seal B; Mullins CD
    J Am Geriatr Soc; 2009 Aug; 57(8):1403-10. PubMed ID: 19563521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased adjuvant treatment and improved survival in elderly stage III colon cancer patients in The Netherlands.
    van Steenbergen LN; Lemmens VEPP; Rutten HJT; Wymenga ANM; Nortier JWR; Janssen-Heijnen MLG
    Ann Oncol; 2012 Nov; 23(11):2805-2811. PubMed ID: 22562836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Causes of mortality in older patients with stage 3 colon cancer.
    Raycraft T; Cheung WY; Yin Y; Speers C; Ko JJ; Mariano C
    J Geriatr Oncol; 2019 Jan; 10(1):138-142. PubMed ID: 29960748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer Database.
    Bergquist JR; Thiels CA; Spindler BA; Shubert CR; Hayman AV; Kelley SR; Larson DW; Habermann EB; Pemberton JH; Mathis KL
    Dis Colon Rectum; 2016 Dec; 59(12):1142-1149. PubMed ID: 27824699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage III Colon Cancer: The Individualized Strategy of Adjuvant Chemotherapy for Aged Under and Over 70.
    Lu CS; Chang PY; Chen YG; Chen JH; Wu YY; Ho CL
    PLoS One; 2015; 10(9):e0138632. PubMed ID: 26382962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the adjuvant chemotherapy effect in elderly stage II and III colon cancer patients in an observational study.
    Kim KY; Cha IH; Ahn JB; Kim NK; Rha SY; Chung HC; Roh JK; Shin SJ
    J Surg Oncol; 2013 May; 107(6):613-8. PubMed ID: 23592499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the efficacy of adjuvant chemotherapy in patients with high-risk stage II colon cancer.
    Cakar B; Varol U; Junushova B; Muslu U; Gursoy Oner P; Gokhan Surmeli Z; Cirak Y; Karaca B; Sezgin C; Karabulut B; Uslu R
    J BUON; 2013; 18(2):372-6. PubMed ID: 23818348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of adjuvant chemotherapy for stage II-III colon cancer patients: An European population-based study.
    Babaei M; Balavarca Y; Jansen L; Lemmens V; van Erning FN; van Eycken L; Vaes E; Sjövall A; Glimelius B; Ulrich CM; Schrotz-King P; Brenner H
    Int J Cancer; 2018 Apr; 142(7):1480-1489. PubMed ID: 29159866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Benefit of adjuvant 5-fluorouracil based chemotherapy for colon cancer: a retrospective cohort study].
    Mondaca S; Villalón C; Leal JL; Zúñiga Á; Bellolio F; Padilla O; Palma S; Garrido M; Nervi B
    Rev Med Chil; 2016 Feb; 144(2):145-51. PubMed ID: 27092667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical outcome of adjuvant FOLFOX4 chemotherapy in elderly patients with stage III colon cancer: single-center study in Korea.
    Kim JY; Kim YJ; Lee KW; Lee JS; Kim DW; Kang SB; Lee HS; Jang NY; Kim JS; Kim JH
    Jpn J Clin Oncol; 2013 Feb; 43(2):132-8. PubMed ID: 23204187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and survival benefit of adjuvant chemotherapy in stage III colon cancer patients: Comparison of overall and age-stratified results by multivariable modeling and propensity score methodology in a population-based cohort.
    Hines RB; Bimali M; Johnson AM; Bayakly AR; Collins TC
    Cancer Epidemiol; 2016 Oct; 44():77-83. PubMed ID: 27513721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer.
    Casadaban L; Rauscher G; Aklilu M; Villenes D; Freels S; Maker AV
    Cancer; 2016 Nov; 122(21):3277-3287. PubMed ID: 27417445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and complications in elderly stage III colon cancer patients in the Netherlands.
    Hoeben KW; van Steenbergen LN; van de Wouw AJ; Rutten HJ; van Spronsen DJ; Janssen-Heijnen ML
    Ann Oncol; 2013 Apr; 24(4):974-9. PubMed ID: 23136227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in Delayed Time to Adjuvant Chemotherapy and Disease-Specific Survival in Stage III Colon Cancer Patients.
    Becerra AZ; Aquina CT; Mohile SG; Tejani MA; Schymura MJ; Boscoe FP; Xu Z; Justiniano CF; Boodry CI; Swanger AA; Noyes K; Monson JR; Fleming FJ
    Ann Surg Oncol; 2017 Jun; 24(6):1610-1617. PubMed ID: 27738848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemotherapy in stage III colon cancer: guideline implementation, patterns of use and outcomes in daily practice in The Netherlands.
    van Gils CW; Koopman M; Mol L; Redekop WK; Uyl-de Groot CA; Punt CJ
    Acta Oncol; 2012 Jan; 51(1):57-64. PubMed ID: 22122695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why adjuvant chemotherapy for stage III colon cancer was not given: Reasons for non-recommendation by clinicians or patient refusal.
    Gilbar P; Lee A; Pokharel K
    J Oncol Pharm Pract; 2017 Mar; 23(2):128-134. PubMed ID: 26692241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.